Transfection Reagents and Equipment Market - 2024-2031
Transfection Reagents and Equipment Marketis is growing with a CAGR of 7.45% during the forecast period 2026-2035.
The Transfection Reagents and Equipment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Transfection Reagents and Equipment Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product type
Both primary and secondary data sources have been used in the global Transfection Reagents and Equipment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Transfection Reagents and Equipment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Transfection Reagents and Equipment Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product type
- Reagents*
- Lipid mediated transfection
- DEAE-dextran
- Calcium phosphate
- Activated dendrimers
- Cationic polymers
- Others
- Equipment
- Liposomes
- Electroporation
- Microinjection
- Perfection
- Biomedical research*
- Cancer research
- Gene expression
- Transgenic models
- Protein production
- Therapeutic delivery
- Pharmaceutical and biotechnology companies *
- Research institutes
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Transfection Reagents and Equipment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Product Type
3.2. Market Snippet by Application
3.3. Market Snippet by End-user
4. DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing incidences of cancer
4.1.1.2. The presence of technological advancements in transfection
4.1.2. Restraints
4.1.2.1. The limitations of transfection reagents
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
6. BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type Segment
6.2. Reagents*
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.2.2.1. Lipid mediated transfection
6.2.2.2. DEAE-dextran
6.2.2.3. Calcium phosphate
6.2.2.4. Activated dendrimers
6.2.2.5. Cationic polymers
6.2.2.6. Others
6.3. Equipment
6.3.1. Introduction
6.3.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.3.2.1. Liposomes
6.3.2.2. Electroporation
6.3.2.3. Microinjection
6.3.2.4. Perfection
6.3.2.5. Others
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application Segment
7.2. Biomedical research*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.2.3. Cancer research
7.2.4. Gene expression
7.2.5. Transgenic models
7.3. Protein production
7.4. Therapeutic delivery
8. BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
8.1.2. Market Attractiveness Index, By End-user Segment
8.2. Pharmaceutical and biotechnology companies *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
8.3. Research institutes
8.4. Others
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. The U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. The Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
10. COMPETITIVE LANDSCAPE
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. COMPANY PROFILES
11.1. Bio-Rad Laboratories, Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Merck KGaA
11.3. Agilent Technologies
11.4. Illumina, Inc.
11.5. Norgen Biotek Corp.
11.6. QIAGEN
11.7. PerkinElmer Inc.
11.8. OriGene Technologies Inc.
11.9. Promega Corporation
11.10. Thermo Fisher Scientific Inc. (LIST NOT EXHAUSTIVE)
12. DATA M
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Product Type
3.2. Market Snippet by Application
3.3. Market Snippet by End-user
4. DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing incidences of cancer
4.1.1.2. The presence of technological advancements in transfection
4.1.2. Restraints
4.1.2.1. The limitations of transfection reagents
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
6. BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type Segment
6.2. Reagents*
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.2.2.1. Lipid mediated transfection
6.2.2.2. DEAE-dextran
6.2.2.3. Calcium phosphate
6.2.2.4. Activated dendrimers
6.2.2.5. Cationic polymers
6.2.2.6. Others
6.3. Equipment
6.3.1. Introduction
6.3.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
6.3.2.1. Liposomes
6.3.2.2. Electroporation
6.3.2.3. Microinjection
6.3.2.4. Perfection
6.3.2.5. Others
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application Segment
7.2. Biomedical research*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
7.2.3. Cancer research
7.2.4. Gene expression
7.2.5. Transgenic models
7.3. Protein production
7.4. Therapeutic delivery
8. BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
8.1.2. Market Attractiveness Index, By End-user Segment
8.2. Pharmaceutical and biotechnology companies *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
8.3. Research institutes
8.4. Others
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. The U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. The Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
10. COMPETITIVE LANDSCAPE
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. COMPANY PROFILES
11.1. Bio-Rad Laboratories, Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Merck KGaA
11.3. Agilent Technologies
11.4. Illumina, Inc.
11.5. Norgen Biotek Corp.
11.6. QIAGEN
11.7. PerkinElmer Inc.
11.8. OriGene Technologies Inc.
11.9. Promega Corporation
11.10. Thermo Fisher Scientific Inc. (LIST NOT EXHAUSTIVE)
12. DATA M
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us
